We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

64 hedge funds and large institutions have $151M invested in Alimera Sciences in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

4% less funds holding

Funds holding: 6764 (-3)

10% less capital invested

Capital invested by funds: $167M → $151M (-$15.9M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

30% less call options, than puts

Call options by funds: $259K | Put options by funds: $370K

Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
1.7%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
7
Increased
27
Reduced
13
Closed
10
Calls
$259K
Puts
$370K
Net Calls
-$111K
Net Calls Change
-$755K

ALIM Hedge Fund Activity: Q1 2015 in Review

64 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2015, worth a combined $151M — down 9.5% from $167M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ALIM and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 27 added.

The largest buyer was North Run Capital, adding an estimated $4.45M. The largest seller was Great Point Partners, cutting an estimated $4.66M.

  • 64 institutional investors held Alimera Sciences (ALIM) as of Q1 2015, down from 67 in Q4 2014.
  • Funds reported $151M of Alimera Sciences stock for Q1 2015, down 9.5% quarter-over-quarter.
  • 7 funds opened new Alimera Sciences positions in Q1 2015 and 10 closed out, a net change of -3 holders.
  • The largest Alimera Sciences buyer in Q1 2015 was North Run Capital, an estimated $4.45M added.
  • The largest Alimera Sciences seller in Q1 2015 was Great Point Partners, an estimated $4.66M sold.

Based on aggregated 13F filings for Q1 2015.